“This study suggests that subclinical synovitis is more prevalent among patients with psoriasis without musculoskeletal involvement than healthy controls, suggesting that imaging may help identify ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for deucravacitinib for the treatment of adults with active psoriatic arthritis (PsA).

Psoriatic arthritis (PsA) is less common among Black people compared to other races, but differences in prevalence may also ...

The diagnosis of several of them can be aided by blood tests and/or imaging. There may not be a cure, but with lifestyle ...

PsA can be challenging, but these expert-approved tips for reframing how you think, talk, and feel about your condition can help you manage.

A successful claim for PIP or ADP is now worth between £29.20 and £187.45 each week in additional financial support and as the benefit is paid every four weeks, this amounts to between £116.80 and ...

Joni Kazantzis didn't think her psoriasis would turn into psoriatic arthritis. But the new diagnosis taught her—and her daughters—some important life lessons.

Discover the signs of psoriatic arthritis, from joint pain and skin changes to nail damage and fatigue, plus the latest treatment options for this condition.

Discover 5 insights about psoriatic arthritis from rheumatology experts, including pain management strategies, treatment approaches and lifestyle factors.

Tremfya reduced signs and symptoms of psoriatic arthritis, as well as progression of structural damage, according to new phase 3 results.

Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research.